Engineered CCL20 locked dimer polypeptide
Abstract:
The present invention provides a CCL20 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of psoriasis, inflammatory disorders and autoimmune disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0